Intuitive Surgical (NASDAQ:ISRG) Director Sells $4,573,400.00 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) Director Gary Guthart sold 10,000 shares of the stock in a transaction on Wednesday, November 4th. The stock was sold at an average price of $457.34, for a total value of $4,573,400.00. Following the completion of the transaction, the director owned 1,194,530 shares of the company’s stock, valued at approximately $546,306,350.20. This trade represents a 0.83% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG opened at $452.80 on Friday. Intuitive Surgical, Inc. has a 1 year low of $328.57 and a 1 year high of $603.88. The firm has a 50-day moving average of $409.93 and a 200 day moving average of $431.89. The stock has a market cap of $156.96 billion, a P/E ratio of 54.75, a price-to-earnings-growth ratio of 3.12 and a beta of 1.45.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, topping analysts’ consensus estimates of $2.65 by $0.35. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The business had revenue of $3.05 billion for the quarter, compared to analysts’ expectations of $2.91 billion. During the same quarter in the prior year, the company earned $2.40 earnings per share. The business’s revenue was up 21.7% compared to the same quarter last year. Research analysts expect that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Cornerstone Advisory LLC grew its stake in Intuitive Surgical by 39.2% during the third quarter. Cornerstone Advisory LLC now owns 809 shares of the medical equipment provider’s stock valued at $329,000 after acquiring an additional 228 shares in the last quarter. Condor Capital Management increased its holdings in Intuitive Surgical by 5.3% in the 3rd quarter. Condor Capital Management now owns 1,445 shares of the medical equipment provider’s stock valued at $588,000 after acquiring an additional 73 shares during the last quarter. Diversified Trust Co lifted its stake in Intuitive Surgical by 52.0% in the 3rd quarter. Diversified Trust Co now owns 4,680 shares of the medical equipment provider’s stock worth $1,903,000 after purchasing an additional 1,601 shares in the last quarter. ProVise Management Group LLC lifted its stake in Intuitive Surgical by 36.8% in the 3rd quarter. ProVise Management Group LLC now owns 1,096 shares of the medical equipment provider’s stock worth $446,000 after purchasing an additional 295 shares in the last quarter. Finally, EagleClaw Capital Managment LLC lifted its stake in Intuitive Surgical by 51.2% in the 3rd quarter. EagleClaw Capital Managment LLC now owns 18,527 shares of the medical equipment provider’s stock worth $7,534,000 after purchasing an additional 6,277 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several recent research reports. Truist Financial cut their price target on Intuitive Surgical from $580.00 to $510.00 and set a “buy” rating on the stock in a research note on Thursday, July 16th. Piper Sandler reiterated an “overweight” rating on shares of Intuitive Surgical in a research note on Friday, August 21st. KeyCorp reissued an “overweight” rating on shares of Intuitive Surgical in a report on Wednesday, August 12th. Robert W. Baird increased their target price on Intuitive Surgical from $513.00 to $550.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 21st. Finally, Citigroup reduced their price target on Intuitive Surgical from $590.00 to $500.00 and set a “buy” rating for the company in a report on Friday, July 17th. One investment analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $493.54.

Key Intuitive Surgical News

Here are the key news stories impacting Intuitive Surgical this week:

• Positive Sentiment: Da Vinci system placements increased 28% year over year to 546 in the third quarter of 2026, and net placements rose 40%, expanding the installed base and supporting future revenue from instruments and services. Article: ISRG System Placements Rise 28%
• Neutral Sentiment: Analysts caution that the placement jump may have been driven partly by multisystem orders and upgrades, so it does not necessarily signal a broad-based increase in hospital capital spending or guarantee the pace will continue. Article: ISRG System Placements Rise 28%: Is Capital Equipment Demand Rising?
• Neutral Sentiment: Recent Zacks coverage says ISRG is attracting investor attention but, in the information provided, identifies no new fundamental development that would explain a change in the stock’s prospects. Article: ISRG is Attracting Investor Attention
• Negative Sentiment: Directors Gary Guthart and Craig Barratt reported sales of 10,000 and 1,150 shares, respectively. Both transactions were made under pre-arranged Rule 10b5-1 plans, which may lessen their signaling significance, but insider selling can still add a modest sentiment headwind. SEC filing: Gary Guthart transaction SEC filing: Craig Barratt transaction

About Intuitive Surgical